ATE500835T1 - Entzündungshemmende zusammensetzungen und anwendungsverfahren - Google Patents

Entzündungshemmende zusammensetzungen und anwendungsverfahren

Info

Publication number
ATE500835T1
ATE500835T1 AT06824774T AT06824774T ATE500835T1 AT E500835 T1 ATE500835 T1 AT E500835T1 AT 06824774 T AT06824774 T AT 06824774T AT 06824774 T AT06824774 T AT 06824774T AT E500835 T1 ATE500835 T1 AT E500835T1
Authority
AT
Austria
Prior art keywords
methods
compositions
inflammatory
inflammatory compositions
inflammatory agent
Prior art date
Application number
AT06824774T
Other languages
English (en)
Inventor
Jean Holland
Janeta Nikolovski
Peter Lyte
Michael Southall
Vivian Zhu
Original Assignee
Johnson & Johnson Consumer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37804507&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE500835(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Johnson & Johnson Consumer filed Critical Johnson & Johnson Consumer
Application granted granted Critical
Publication of ATE500835T1 publication Critical patent/ATE500835T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT06824774T 2005-08-31 2006-07-24 Entzündungshemmende zusammensetzungen und anwendungsverfahren ATE500835T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/215,912 US8758838B2 (en) 2005-08-31 2005-08-31 Anti-inflammatory compositions and methods of use
PCT/US2006/028520 WO2007027314A2 (en) 2005-08-31 2006-07-24 Anti-inflammatory compositions and methods of use

Publications (1)

Publication Number Publication Date
ATE500835T1 true ATE500835T1 (de) 2011-03-15

Family

ID=37804507

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06824774T ATE500835T1 (de) 2005-08-31 2006-07-24 Entzündungshemmende zusammensetzungen und anwendungsverfahren

Country Status (11)

Country Link
US (1) US8758838B2 (de)
EP (1) EP1940432B1 (de)
CN (1) CN101287480B (de)
AT (1) ATE500835T1 (de)
AU (1) AU2006285299B2 (de)
BR (1) BRPI0615282A2 (de)
CA (1) CA2620763C (de)
DE (1) DE602006020605D1 (de)
ES (1) ES2358925T3 (de)
RU (1) RU2406523C2 (de)
WO (1) WO2007027314A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697152B2 (en) * 2005-08-31 2014-04-15 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
US8758838B2 (en) 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
FR2935378B1 (fr) * 2008-08-29 2015-03-27 Seppic Sa Utiisation de n-acyl aminoacides comme principes actifs cosmetiques et pharmaceutiques, capables de reduire l'etat inflammatoire des fibroblastes replicatifs senescents issus du derme humain adulte; compositions cosmetiques anti-age
FR2935379B1 (fr) * 2008-09-03 2012-08-31 Seppic Sa Utilisation de n-acyl aminoacides comme principe actifs cosmetiques et pharmaceutiques, regulateurs de la proportion de keratinocytes basaux de l'epiderme de la peau humaine exprimant la forme nucleaire de la survivine ; compositions
ES2349976B1 (es) * 2009-05-14 2011-11-10 Sanidad Y Residencias 21 Sa Utilizacion de extractos de hojas de olivo en una composicion farmaceutica para inducir angiogenesis y vasculogenesis.
CA2892408C (en) 2012-12-19 2019-10-08 Colgate-Palmolive Company Oral care composition
CN104593182A (zh) * 2014-12-30 2015-05-06 东莞市高明企业服务有限公司 一种天然植物提取物洗涤液及其制备方法
CN104784074B (zh) * 2015-04-01 2017-11-28 珀莱雅化妆品股份有限公司 一种具有抗敏功效的阳离子纳米乳液及其制备方法
CN107898939A (zh) * 2017-11-06 2018-04-13 康柏利科技（苏州）有限公司 一种具有预防和治疗婴儿湿疹的组合物
US10517855B1 (en) 2019-02-08 2019-12-31 Shibban Krishen Ganju Interleukins activity inhibiting composition
KR20220085773A (ko) * 2019-09-18 2022-06-22 파마 코스메틱스 리서치 엘엘씨 엔도칸나비노이드 모방 및 항염 화합물을 함유하는 조성물, 이의 제조 방법 및 용도

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2507477A1 (fr) 1981-06-12 1982-12-17 Roussel Uclaf Nouveau procede de preparation d'un extrait de feuilles d'olea europea riche en oleuropeine, produits obtenus, application a titre de medicaments et compositions les renfermant
JPS5823612A (ja) 1981-08-04 1983-02-12 Osaka Chem Lab 生薬成分含有化粧料組成物
SE453724B (sv) 1985-04-18 1988-02-29 Nobel Consumer Goods Ab Hudvardsmedel
AU618517B2 (en) 1986-12-23 1992-01-02 Eugene J. Van Scott Additives enhancing topical actions of therapeutic agents
US5922701A (en) 1992-05-01 1999-07-13 University Of Utah Research Foundation Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
JPH06172152A (ja) 1992-12-04 1994-06-21 Sunstar Inc にきび予防化粧料組成物
JPH09157172A (ja) 1995-12-13 1997-06-17 Lion Corp 皮膚外用剤及び湿疹薬
FR2760362B1 (fr) 1997-03-10 2000-08-11 Vitasterol Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
FR2765109B1 (fr) * 1997-06-25 2001-02-09 Seppic Sa Composition comprenant un lipoaminoacide et les constituants d'un extrait de plantes riches en tanins et utilisation en cosmetique
IT1298283B1 (it) 1998-02-19 1999-12-20 B & T S R L Uso dell'estratto delle foglie di olea europea come antiradicalico
JP3929613B2 (ja) 1998-08-20 2007-06-13 株式会社カネボウ化粧品 化粧料
DE69915991T2 (de) 1998-12-18 2005-03-10 Société d'Exploitation de Produits pour les Industries Chimiques S.E.P.P.I.C. Verwendung in der Kosmetik eines, gegen Elektrolyten, stabilen inversen Latex
JP2000247829A (ja) 1999-02-24 2000-09-12 Mikimoto Pharmaceut Co Ltd 化粧料、医薬部外品、医薬品、食品
US6440432B1 (en) * 1999-03-18 2002-08-27 Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. Skin cosmetic compositions containing dextran or maltodextrin and a weak carboxylic acid
FR2790977B1 (fr) * 1999-03-19 2003-09-12 Seppic Sa Nouvelles emulsions eau-dans-huile stables contenant un emulsionnant a base d'oleyl- et/ou d'isostearyl-glycoside
GB9908976D0 (en) * 1999-04-21 1999-06-16 Breed Automotive Tech A seat belt retractor
JP2001002550A (ja) 1999-06-18 2001-01-09 Ichimaru Pharcos Co Ltd オリーブ葉抽出物、皮膚外用剤又は浴用剤への応用
US6762158B2 (en) * 1999-07-01 2004-07-13 Johnson & Johnson Consumer Companies, Inc. Personal care compositions comprising liquid ester mixtures
CN1119155C (zh) * 2000-02-01 2003-08-27 孟承光 一种用于治疗皮肤损伤的中药组合物
FR2808191B1 (fr) * 2000-04-28 2004-03-05 Oreal Extrait de vegetal de l'espece olea europaea comme inhibiteur de no-synthase et utilisations
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
US20050003023A1 (en) * 2002-06-28 2005-01-06 Meisner Lorraine Faxon Topical composition for the treatment of psoriasis and related skin disorders
JP4693012B2 (ja) 2000-06-29 2011-06-01 一丸ファルコス株式会社 光毒性抑制剤
FR2818149A1 (fr) 2000-12-15 2002-06-21 Oreal Composition, notamment cosmetique, comprenant la 7-hydroxy dhea et/ou 7-ceto dhea et au moins un inhibiteur de 5 alpha-reductase
US20030077343A1 (en) 2001-03-16 2003-04-24 Martin Katharine M. Composition containing feverfew extract and use thereof
JP4583655B2 (ja) 2001-05-08 2010-11-17 株式会社ディーエイチシー 抗アレルギー皮膚外用組成物
FR2835252B1 (fr) * 2002-01-25 2005-08-05 Seppic Sa Utilisation d'un compose inactivant la proteine kinase a dans une composition contenant un milieu cosmetiquement acceptable, pour eclaicir la peau
US20030224028A1 (en) * 2002-05-13 2003-12-04 Societe L'oreal S.A. Metal complexes for promoting skin desquamation and/or stimulating epidermal renewal
FR2848116B1 (fr) 2002-12-10 2007-01-05 Nuxe Lab Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
FR2851460B1 (fr) * 2003-02-21 2007-05-11 Seppic Sa Utilisation de n-lauroyl aminoacides comme actif cosmetique et pharmaceutique amincissant
US20050129759A1 (en) * 2003-12-16 2005-06-16 Milan Sojka Sustained release compositions and controlled delivery method
WO2005063195A2 (en) 2003-12-30 2005-07-14 Med Care S.R.L. Compositions comprising vitamins and/or derivatives thereof stabilised with olea europea extract and/or ionene polymers
US7691399B2 (en) 2004-02-03 2010-04-06 Alberto Culver Company Cosmetic compositions with long lasting skin moisturizing properties
US20050186269A1 (en) * 2004-02-25 2005-08-25 Udell Ronald G. Stabilized feverfew formulations
CN100475246C (zh) * 2004-03-25 2009-04-08 贵阳卫生材料厂 一枝蒿伤湿祛痛膏
US7341752B2 (en) * 2005-08-30 2008-03-11 Academia Sinica Antibacterial treatment and composition
US8697152B2 (en) * 2005-08-31 2014-04-15 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and personal care compositions comprising olive leaf (Olea europea) extract
US8758838B2 (en) 2005-08-31 2014-06-24 Johnson & Johnson Consumer Companies, Inc. Anti-inflammatory compositions and methods of use
JP4893148B2 (ja) 2006-08-09 2012-03-07 株式会社日立製作所 形状簡略化装置及びそれに用いられるプログラム

Also Published As

Publication number Publication date
AU2006285299A1 (en) 2007-03-08
CA2620763A1 (en) 2007-03-08
CN101287480A (zh) 2008-10-15
US20070048396A1 (en) 2007-03-01
CA2620763C (en) 2014-11-04
RU2406523C2 (ru) 2010-12-20
BRPI0615282A2 (pt) 2011-05-17
WO2007027314A2 (en) 2007-03-08
AU2006285299B2 (en) 2012-04-05
EP1940432A4 (de) 2009-10-21
CN101287480B (zh) 2013-05-15
EP1940432A2 (de) 2008-07-09
WO2007027314A3 (en) 2007-10-11
RU2008112173A (ru) 2009-10-10
EP1940432B1 (de) 2011-03-09
US8758838B2 (en) 2014-06-24
DE602006020605D1 (de) 2011-04-21
ES2358925T3 (es) 2011-05-16

Similar Documents

Publication Publication Date Title
ATE350409T1 (de) Ampholytisches copolymer und dessen verwendung
NO20085338L (no) Substituerte 1,3-difenylpropanderivater, sammensetninger og anvendelser derav
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
CY1109465T1 (el) Νεες φαρμακευτικες φαρμακοτεχνικες μορφες μονταφινιλης
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
DK3311805T3 (da) Sammensætninger, der omfatter svært vandopløselige farmaceutiske midler og antimikrobielle midler
AR030185A1 (es) Glutarimidas sustituidas, su preparacion, medicamentos que las contienen, y uso de las mismas para la fabricacion de medicamentos, especialmente inmunomoduladores, como asi tambien inhibidores de angiopatias y/o enfermedades hematologicas/oncologicas
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
NO20052306D0 (no) Dispergerbare farmasoytiske blandinger.
DK1525177T3 (da) Substituerede 1,3-diphenylprop-2-en-1-on-derivater, fremstilling og anvendelse deraf
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
BRPI0508263B8 (pt) derivados de 1, 2, 3, 4-tetra-hidro-isoquinolina, composição farmacêutica, e, uso de derivado de 1, 2, 3, 4-tetra-hidro-isoquinolina
HRP20090381T1 (en) Compositions comprising drospirenone molecularly dispersed
WO2007070052A3 (en) Pharmaceutical compositions and methods for treating or preventing oxalate-related disease
ATE445389T1 (de) Liposomale glucocorticoide
TW200505875A (en) Novel compounds
PA8583601A1 (es) Derivados de pirrolidona como inhibidores de maob
EA200600403A1 (ru) Препараты кладрибина для улучшенной пероральной доставки и доставки через слизистые оболочки
BRPI0508137A (pt) composição de tratamento dos cabelos, método de alisamento de cabelos e uso da composição
ATE500835T1 (de) Entzündungshemmende zusammensetzungen und anwendungsverfahren
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
ATE454385T1 (de) Hiv-integrase-hemmers, pharmazeutischen zusammensetzung und ihre anwendung
CO5660287A2 (es) Derivados de tetrahidrocarbazol y su uso farmaceutico
ITMI20031396A1 (it) Composizione per uso farmaceutico o dietetico o cosmetico dotata di attivita' antiossidante.
DE60134414D1 (de) 4-pyrimidinamine derivate, pharmazeutische zusammenstellungen und verwandte methoden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties